127 related articles for article (PubMed ID: 12829924)
1. Primary intestinal posttransplant T-cell lymphoma.
Michael J; Greenstein S; Schechner R; Tellis V; Vasovic LV; Ratech H; Glicklich D
Transplantation; 2003 Jun; 75(12):2131-2. PubMed ID: 12829924
[TBL] [Abstract][Full Text] [Related]
2. Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients.
Wu H; Wasik MA; Przybylski G; Finan J; Haynes B; Moore H; Leonard DG; Montone KT; Naji A; Nowell PC; Kamoun M; Tomaszewski JE; Salhany KE
Am J Clin Pathol; 2000 Apr; 113(4):487-96. PubMed ID: 10761449
[TBL] [Abstract][Full Text] [Related]
3. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
[TBL] [Abstract][Full Text] [Related]
4. Complete regression of cutaneous B-cell lymphoma in a renal transplant patient after conversion from cyclosporin to sirolimus.
Mohsin N; Budruddin M; Kamble P; Khalil M; Pakkyarra A; Jha A; Mohammed E; Ahmed H; Ahmed J; Thomas S; Campistol JM; Daar A
Transplant Proc; 2007 May; 39(4):1267-71. PubMed ID: 17524950
[TBL] [Abstract][Full Text] [Related]
5. Mucosa-associated lymphoid tissue gastric lymphoma regression in a renal transplant patient after conversion of the immunosuppression to sirolimus: a case report.
Lasmar EP; Coelho LG; Lasmar MF; Lasmar LF; Lima PV; Nogueira AF
Transplant Proc; 2009 Apr; 41(3):959-61. PubMed ID: 19376398
[TBL] [Abstract][Full Text] [Related]
6. Posttransplant cutaneous T-cell lymphoma: case reports and review of the association of calcineurin inhibitor use with posttransplant lymphoproliferative disease risk.
Pomerantz RG; Campbell LS; Jukic DM; Geskin LJ
Arch Dermatol; 2010 May; 146(5):513-6. PubMed ID: 20479299
[TBL] [Abstract][Full Text] [Related]
7. Posttransplant lymphoproliferative disorders in transplant recipients.
Timurağaoğlu A; Uğur-Bilgin A; Colak D; Tuncer M; Gölbaşi I; Hazar V; Kiliçarsłan B; Undar L; Demirbaş A
Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
[TBL] [Abstract][Full Text] [Related]
8. Features of intestinal T-cell lymphomas in Chinese population without evidence of celiac disease and their close association with Epstein-Barr virus infection.
Zhang WY; Li GD; Liu WP; Ouyang Q; Ren XC; Li FY; Xu H
Chin Med J (Engl); 2005 Sep; 118(18):1542-8. PubMed ID: 16232331
[TBL] [Abstract][Full Text] [Related]
9. Chylous ascites in a renal transplant recipient under sirolimus (rapamycin) treatment.
Castro G; Freitas C; Beirão I; Rocha G; Henriques AC; Cabrita A
Transplant Proc; 2008 Jun; 40(5):1756-8. PubMed ID: 18589188
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus in pediatric patients: results in the first 6 months post-renal transplant.
Hymes LC; Warshaw BL
Pediatr Transplant; 2005 Aug; 9(4):520-2. PubMed ID: 16048606
[TBL] [Abstract][Full Text] [Related]
11. Monomorphic Epstein-Barr virus (EBV)-associated large B-cell posttransplant lymphoproliferative disorder presenting as a tongue ulcer in a pancreatic transplant patient.
Bruce AJ; Subtil A; Rogers RS; Castro LA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):e24-8. PubMed ID: 16997090
[TBL] [Abstract][Full Text] [Related]
12. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.
Yin CC; Medeiros LJ; Abruzzo LV; Jones D; Farhood AI; Thomazy VA
Am J Clin Pathol; 2005 Feb; 123(2):222-8. PubMed ID: 15842046
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus delays recovery from posttransplant renal failure in kidney graft recipients.
Boratyńska M; Banasik M; Patrzalek D; Szyber P; Klinger M
Transplant Proc; 2005 Mar; 37(2):839-42. PubMed ID: 15848550
[TBL] [Abstract][Full Text] [Related]
14. Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine.
Romagnoli J; Citterio F; Nanni G; Favi E; Tondolo V; Spagnoletti G; Salerno MP; Castagneto M
Transplant Proc; 2006 May; 38(4):1034-6. PubMed ID: 16757255
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous T-cell lymphoma occurring after organ transplantation.
Ravat FE; Spittle MF; Russell-Jones R
J Am Acad Dermatol; 2006 Apr; 54(4):668-75. PubMed ID: 16546591
[TBL] [Abstract][Full Text] [Related]
16. Individualization of immunosuppressive therapy. III. Sirolimus associated with a reduced incidence of malignancy.
Yakupoglu YK; Buell JF; Woodle S; Kahan BD
Transplant Proc; 2006 Mar; 38(2):358-61. PubMed ID: 16549120
[TBL] [Abstract][Full Text] [Related]
17. Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin.
Verma S; Frambach GE; Seilstad KH; Nuovo G; Porcu P; Magro CM
J Cutan Pathol; 2005 Aug; 32(7):474-83. PubMed ID: 16008691
[TBL] [Abstract][Full Text] [Related]
18. Posttransplant lymphoproliferative disorder presenting as CD30+, ALK+, anaplastic large cell lymphoma in a child.
Sebire NJ; Malone M; Ramsay AD
Pediatr Dev Pathol; 2004; 7(3):290-3. PubMed ID: 15148593
[TBL] [Abstract][Full Text] [Related]
19. Impact of sirolimus treatment in kidney allograft recipients with prolonged cold ischemia times: 5-year outcomes.
Boratynska M; Banasik M; Patrzalek D; Klinger M
Exp Clin Transplant; 2008 Mar; 6(1):59-66. PubMed ID: 18405247
[TBL] [Abstract][Full Text] [Related]
20. Brain tumor as an unusual presentation of posttransplant lymphoproliferative disorder.
Azarpira N; Torabineghad S; Rakei M
Exp Clin Transplant; 2009 Mar; 7(1):58-61. PubMed ID: 19364315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]